国: 南アフリカ
言語: 英語
ソース: South African Health Products Regulatory Authority (SAHPRA)
Nbi
TETAGAM IM 250 IU solution for intramuscular injection TETAGAM IM 500 IU solution for intramuscular injection REGISTRATION NUMBER Tetagam IM 250 IU: T/30.2/743 Tetagam IM 500 IU: T/30.2/744 PROPRIETARY NAME (and dosage form): TETAGAM IM 250 IU solution for intramuscular injection TETAGAM IM 500 IU solution for intramuscular injection DESCRIPTIVE NAME OF THE MEDICINE Human tetanus immunoglobulin PHARMACOLOGICAL CLASSIFICATION A 30.2 Biologicals (Antibodies) SCHEDULING STATUS S4 COMPOSITION Tetagam IM contains gammaglobulin derived from pooled human plasma, sourced from non-remunerated healthy donors, with a high titre of antibodies to tetanus toxin. Each unit of plasma has been individually tested and found non-reactive for hepatitis B surface antigen, antibodies to the hepatitis C virus and antibodies to the human immunodeficiency viruses, HIV-1 and HIV-2, using approved methods. Tetagam IM is prepared by cold ethanol fractionation to further reduce the risk of viral transmission. Each ampoule Tetagam IM 250 IU contains 250 IU (125 IU/mL) tetanus antibodies. Each ampoule Tetagam IM 500 IU contains 500 IU (500 IU/mL) tetanus antibodies. This preparation contains no antimicrobial preservative and is stabilised with glycine. IDENTIFICATION A clear, pale yellow or light brown liquid exhibiting slight opalescence. PHARMACOLOGICAL ACTION OF THE MEDICINE Tetanus immunoglobulin confers passive immunity against tetanus. INDICATIONS Prophylaxis in patients with wounds contaminated by Clostridium tetani in conjunction with appropriate wound management and simultaneous active immunisation using a different injection site and syringe. IMMUNE STATUS CLEAN MINOR WOUNDS (Tetanus Infection Unlikely) CLEAN MINOR WOUNDS (Tetanus Infection Unlikely) ALL OTHER WOUNDS (Dirty Wounds) ALL OTHER WOUNDS (Dirty Wounds) Tet 完全なドキュメントを読む